Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies

Europace

Volumn 16, Issue 1, 2014, Pages 55-62

  Makki, Nader ^a   Swaminathan, Paari Dominic ^b   Hanmer, Janel ^a   Olshansky, Brian ^a  

^a UNIVERSITY OF IOWA   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Implantable cardioverter defibrillator; Kidney disease; Mortality; Sudden death

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; END STAGE RENAL DISEASE; EVIDENCE BASED MEDICINE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SUDDEN CARDIAC DEATH; SURVIVAL; SYSTEMATIC REVIEW; UNITED STATES;

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY DISEASE; MORTALITY; SUDDEN DEATH;

AGED; CAUSALITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; OBSERVATIONAL STUDY AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE;

EID: 84891347574     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut277     Document Type: Article

References (40)

1. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-73.
2. Alsheikh-Ali AA, Trikalinos TA, Ruthazer R, Terrin N, Wong JB, Sarnak MJ et al. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J 2011;161:204-9 e1.
3. Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009;103:735-41.
4. Pun PH, Middleton JP. Sudden cardiac death in hemodialysis patients: a comprehensive care approach to reduce risk. Blood Purif 2012;33:183-9.
5. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-47.
6. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J et al. Renal insufficiency and the riskofinfection from pacemakeror defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-5.
7. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007;49:656-63.
8. Tompkins C, McLean R, Cheng A, Brinker JA, Marine JE, Nazarian S et al. End-stage renal disease predicts complications in pacemaker and ICD implants. J Cardiovasc Electrophysiol 2011;22:1099-104.
9. Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G. Implantable cardioverter defib-rillator therapy in chronic kidney disease: a meta-analysis. Europace 2009;11: 1469-75.
10. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-90.
11. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
12. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM et al. Current methods ofthe US Preventive Services Task Force: areviewofthe process. Am J Prev Med 2001;20:21-35.
13. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994;271:1615-9.
14. Hage FG, Aljaroudi W, Aggarwal H, Bhatia V, Miller J, Doppalapudi H et al. Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: primary versus secondary prevention. Int J Cardiol 2013;165:113-6.
15. Alla VM, Anand K, Hundal M, Chen A, Karnam S, Hee T et al. Impact of moderate to severe renal impairment on mortality and appropriate shocks in patients with implantable cardioverter defibrillators. Cardiol Res Pract 2010;2010:150285.
16. Hager CS, Jain S, Blackwell J, Culp B, Song J, Chiles CD. Effect of renal function on survival after implantable cardioverter defibrillator placement. Am J Cardiol 2010; 106:1297-300.
17. Levy R, Della Valle A, Atav AS, ur Rehman A, Sklar AH, Stamato NJ. The relationship between glomerular filtration rate and survival in patients treated with an implanta-ble cardioverter defibrillator. Clin Cardiol 2008;31:265-9.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
19. Greene WH. Economic analysis. 7th ed., Upper Saddle River, New Jersey: Prentice Hall; 2011; 1232.
20. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999;18:2693-708.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
22. Hiremath S, Punnam SR, Brar SS, Goyal SK, Gardiner JC, Shah AJ et al. Implantable defibrillators improve survival inend-stage renal disease: results from a multi-center registry. Am J Nephrol 2010;32:305-10.
23. Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA et al. Trends in the use and outcomesofimplantable cardioverter- defibrillatorsinpatients undergoing dialysis in the United States. Am J Kidney Dis 2011;58:409-17.
24. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival ofdia-lysis patients after cardiac arrest and the impact of implantable cardioverter defibril-lators. Kidney Int 2005;68:818-25.
25. Khan F, Adelstein E, Saba S. Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients. J Interv Card Electrophysiol 2010;28:117-23.
26. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
27. Bruch C, Bruch C, Sindermann J, Breithardt G, Gradaus R. Prevalence and prognostic impactofcomorbidities in heart failure patients with implantable cardioverter defib-rillator. Europace 2007;9:681-6.
28. Cheema A, Singh T, Kanwar M, Chilukuri K, Maria V, Saleem F et al. Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients. Cardiol Res Pract 2010; Article 989261.
29. Chen-Scarabelli C, Scarabelli TM. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007;30:371-6.
30. Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007;30:207-13.
31. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibril-lator implantation in patients with renal insufficiency.JCardiovasc Electrophysiol 2006; 17:940-3.
32. Koplan BA, Epstein LM, Albert CM, Stevenson WG. Survival inoctogenarians receiving implantable defibrillators. Am Heart J 2006;152:714-9.
33. Parkash R, Stevenson WG, Epstein LM, Maisel WH. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 2006;151:397-403.
34. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006;3:1196-201.
35. Schefer T, Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Duru F. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function. Europace 2008;10:1052-9.
36. Turakhia MP, Varosy PD, Lee K, Tseng ZH, Lee R, Badhwar N et al. Impact of renal function on survival in patients with implantable cardioverter- defibrillators. Pacing Clin Electrophysiol 2007;30:377-84.
37. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T et al. Impact of chronic kidney disease upon survival among implantable cardioverter- defibrillator recipients. J Interv Cardiac Electrophysiol 2004;11:199-204.
38. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Character-istics of sudden death in hemodialysis patients. Kidney Int 2006;69:2268-73.
39. Dasselaar JJ, Slart RH, Knip M, Pruim J, Tio RA, McIntyre CW et al. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 2009;24:604-10.
40. Morris ST, Galiatsou E, Stewart GA, Rodger RS, Jardine AG. QT dispersion before and after hemodialysis. J Am Soc Nephrol 1999;10:160-3.